» Authors » Felipe Rodriguez de Castro

Felipe Rodriguez de Castro

Explore the profile of Felipe Rodriguez de Castro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 624
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Suarez-Pajes E, Marcelino-Rodriguez I, Hernandez Brito E, Gonzalez-Barbuzano S, Ramirez-Falcon M, Tosco-Herrera E, et al.
Respir Res . 2024 Oct; 25(1):374. PMID: 39415140
Background: Community-acquired pneumonia (CAP) is associated with high morbidity and hospitalization rate. In infectious diseases, host genetics plays a critical role in susceptibility and immune response, and the immune pathways...
2.
Valencia-Gallardo J, Rodriguez de Castro F, Sole-Violan J, Carlos Rodriguez-Gallego J
Med Intensiva (Engl Ed) . 2024 Jul; 48(9):543-545. PMID: 38997906
No abstract available.
3.
Rodriguez de Castro F, Carrillo Diaz T, Gual I Sala A, Pales Argullos J
Gac Sanit . 2024 Apr; 38 Suppl 1():102380. PMID: 38643057
The problems posed by medical education in Spain are diverse. This paper analyzes the system currently used to select candidates who will be admitted to a public faculty of medicine...
4.
Garcia-Garcia A, de Diego R, Flores C, Rinchai D, Sole-Violan J, Deya-Martinez A, et al.
J Exp Med . 2023 Mar; 220(5). PMID: 36880831
X-linked recessive deficiency of TLR7, a MyD88- and IRAK-4-dependent endosomal ssRNA sensor, impairs SARS-CoV-2 recognition and type I IFN production in plasmacytoid dendritic cells (pDCs), thereby underlying hypoxemic COVID-19 pneumonia...
5.
Zhang Q, Pizzorno A, Miorin L, Bastard P, Gervais A, Le Voyer T, et al.
J Exp Med . 2022 Sep; 219(11). PMID: 36112363
Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-α2 alone (five patients) or...
6.
Valencia Gallardo J, Violan J, Rodriguez de Castro F
Arch Bronconeumol . 2021 Nov; PMID: 34776584
No abstract available.
7.
Valencia Gallardo J, Violan J, Rodriguez de Castro F
Arch Bronconeumol . 2021 May; 58(1):102-103. PMID: 33966921
No abstract available.
8.
Sole-Violan J, Hernandez-Brito E, Valencia-Gallardo J, Herrera-Ramos E, Borderias L, Briones M, et al.
ERJ Open Res . 2021 Feb; 7(1). PMID: 33532473
https://bit.ly/3jc9SmR.
9.
Caminero Luna J, Perez Mendoza G, Rodriguez de Castro F
Med Clin (Barc) . 2021 Feb; 156(8):393-401. PMID: 33531151
Drug-resistant tuberculosis, especially those with resistance to rifampicin (RR-TB), has become one of the main obstacles to achieving the dream of eradicating tuberculosis. Furthermore, it is necessary to combine three...
10.
Garcia-Laorden M, Hernandez-Brito E, Munoz-Almagro C, Pavlovic-Nesic S, Rua-Figueroa I, Briones M, et al.
J Clin Immunol . 2019 Dec; 40(1):203-210. PMID: 31828694
Mannose-binding lectin (MBL)-associated serine protease-2 (MASP-2) is an indispensable enzyme for the activation of the lectin pathway of complement. Its deficiency is classified as a primary immunodeficiency associated to pyogenic...